Investors have maintained a high level of interest in the pharmaceuticals and life sciences (PLS) and healthcare services (HCS) sectors, particularly since the start of the pandemic. The sector’s historic position as a defensive refuge for investors during difficult economic times has helped it attract new investor interest (for example, from infrastructure funds) and a lot of capital chasing a safe harbour. M&A deal activity and valuations are running high, and PwC expects this trend to continue for the next 12 to 18 months.
Read the full article: Global M&A Industry Trends in Health Industries //
Source: https://www.pwc.com/gx/en/services/deals/trends/health-industries.html